Author： Jătariu Anca N. Popa Marcel Peptu Cătălina A.
Publisher： Informa Healthcare
ISSN： 1061-186X
Source： Journal of Drug Targeting, Vol.18, Iss.4, 2010-05, pp. : 243-253
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The human body has adapted to defend against the aggressive biological or chemical agents. As a result, the defence mechanisms of the human body became barriers for the drug delivery. Theoretically, any problem that prevents a drug from reaching its site of action is considered to be a barrier to drug delivery. The aim of this article is to discuss the possibility of three types of nanocarriers (nanoparticles, liposomes, and solid lipid nanoparticles) to help the drugs to pass some important biological barriers (blood–brain barriers, skin, eye, and tumors) using different strategies/designs of drug delivery systems.
Related content
Access to resources
Recommend
Editorial (Thematic Issue: Pharmacological Targeting of Biological Barriers)
Current Pharmaceutical Design, Vol. 22, Iss. 35, 2016-11 ,pp. :